Herpes Cure Research in 2027: Vaccines, Gene Editing and New Drugs
HSV-1 and HSV-2 together infect more than 4 billion people. WHO estimates that about 3.8 billion people under 50 carry HSV-1 and roughly 520 million people...
Read More5 articles tagged with this topic
HSV-1 and HSV-2 together infect more than 4 billion people. WHO estimates that about 3.8 billion people under 50 carry HSV-1 and roughly 520 million people...
Read MoreChinese biotech company BDgene Therapeutics, based in Shanghai, has developed BD111, a gene-editing therapy using CRISPR-Cas9 technology to target and remove...
Read MoreHerpes simplex virus (HSV), which causes oral and genital herpes, remains a lifelong infection with no current cure. Traditional antiviral medications manage...
Read MoreEditorial note: This article covers herpes cure research as it stood in 2025. For the current picture, including Moderna's exit from herpes vaccines and the...
Read MoreIn a remarkable development that could change the lives of millions affected by herpes, researchers at the Fred Hutchinson Cancer Center have made a...
Read More